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We assessed the capacity of HIV self-testing to promote testing among untested men who
have sex with men (MSM) and determined the most benefited subpopulations.
Methods
An online questionnaire was disseminated on several gay websites in Spain from Septem-
ber 2012 to April 2013. We used Poisson regression to estimate factors associated with the
intention to use self-testing if already available. Among those who reported intention of use,
we assessed several aspects related to the testing and linkage to care process by type of
barrier reported: low perceived risk (LR), structural barriers (SB) and fear of testing positive
(FTP).
Results
Of 2589 never-tested MSM, 83% would have used self-testing if already available. Intention
of use was associated with age�30 (adj.PR, 95%CI: 1.05, 1.01–1.10), having had pro-
tected (adj.PR, 95%CI: 1.15, 1.02–1.30) or unprotected (adj.PR, 95%CI: 1.21, 1.07–1.37)
anal intercourse and reporting FTP (adj.PR, 95%CI: 1.12, 1.05–1.20) or SB to access HIV
testing (adj.PR, 95%CI: 1.23, 1.19–1.28). Among those who reported intention of using a
self-testi, 78.3% declared it their preferred option (83.8% in the SB group; p<0.001), and
56.8% would always use this testing option (60.9% among the SB group; p = 0.001). In the
case of obtaining a positive self-test, 69.3% would seek confirmatory testing, 15.3% would
self-test again before taking any decision and 13.0% reported not being sure of what they
would do.
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Conclusion
HIV self-testing in Spain has the potential of becoming a highly used testing methodology
for untested MSM and could represent the gateway to testing especially among older, at risk
MSM who report SB or FTP as main barriers to testing.
Introduction
In Spain and in the rest of Western Europe, men who have sex with men (MSM) are the popu-
lation most affected by HIV. Of the 1270 new HIV cases notified among MSM during 2016
39.4% were diagnosed at a late stage of infection (< 350mm3 CD4 count at diagnosis) [1].
From a public health perspective, to promote earlier diagnosis and to reduce the undiagnosed
fraction of the epidemic is one of the main priorities in HIV prevention programs worldwide
because treatment reduces infectiousness and contributes to stop onward transmission [2, 3].
Recommendations for MSM are that an HIV test should be performed at least every 12
months and every 3 when having unprotected sex with casual partners [4]. However, studies
across Europe point out that these recommendations are far from being met [5–8]. In fact, the
first European men who have sex with men internet survey (EMIS) found that the percentage
of untested MSM in western European countries ranged from 16.2% in France to 37.2% in
Finland [9].
In Spain, HIV testing is offered free of cost at all levels of the public health system. It is also
performed in a network of sexual health clinics and units that not only offer it free of cost but
also anonymously. Confidential and anonymous rapid testing is also conducted for free by a
number of community based organisations (CBO) and, in 5 regions, there are also pharmacy
based rapid testing programmes where those who wish, can get tested by a pharmacist. In spite
of the variety of settings, 26.1% of MSM in Spain have never been tested for HIV [10].
Barriers to testing include reasons related to risk perception, fear of stigma and discrimina-
tion and to health consequences derived from a positive result [11]. Additionally, there are
also a number of structural barriers related to the characteristics of the diagnostic settings that
include lack of anonymity and or/ confidentiality, having to wait, having to return to receive
the result of a test, and the need to discuss sexual behaviours [11].
In this sense, self-testing is a methodology that could help to alleviate some of the aforemen-
tioned barriers. First approved in the US in 2012, self-testing has slowly but steadily spread
across high-income countries. At present it is being marketed in the United Kingdom (UK),
France, Belgium and Italy. In Spain self-testing kits started to be commercialized in January
2018 [12]. Self-testing provides individuals with the opportunity of learning their serostatus
conveniently since it requires no appointments, no queues, no time invested in getting to test-
ing sites and no pre and post-test discussion. On the other hand it also raises some concerns.
The lack of face to face pre-test contact with a professional is one of the most common ones.
Thus, it is important to provide good written and online materials to inform potential users
both about the benefits and limitations (i.e window period and the need of a confirmation
test) of self-testing. Coping with a positive self-test alone is another concern and support
mechanisms need to be put into place to offer support and information for those in this situa-
tion. Finally there are also concerns about users who obtain a reactive self-test and do not seek
confirmation testing and subsequent linkage to specialist care [13–16].
If self-testing is capable of eliminating some of the known barriers and of facilitating access
to HIV testing among those who remain untested, it is crucial to know which subpopulations
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would use it. The literature assessing the impact that the introduction of self-testing could have
in untested MSM is very limited and mostly comes from Australia and the US. In Europe, we
found very few studies assessing this aspect in this population [17–19] and none of them focus
on never tested individuals. Furthermore, we do not know what type of barriers self-testing
would help to remove and what would happen in the case of receiving a positive result. Acts
following a reactive self-test and preferences regarding confirmation sites remain unknown
and are important elements that need to be taken into account for the future development of
the strategy.
In the present paper we assess the impact that self-testing could have among untested MSM
in Spain. We identify the subgroups that would benefit the most from its introduction and
assess self-testing’s capacity of overcoming barriers that deter people from testing. Additionally
we also investigate several key aspects related to the testing process and linkage to care that
need to be considered to assure an effective introduction of this methodology.
Methods
Study participants
Inclusion criteria were being> = 18 years of age and having reported lifetimes sex with other
men. Of the 9489 participants who met the inclusion criteria and self-identified as HIV nega-
tive or had an unknown serostatus, we selected 2818 MSM who reported no previous HIV test-
ing experience. Additionally, we excluded 229 who did not answer the main outcome variable
(would have used self-testing if already available). Thus, 2589 participants were included in the
final analysis. No incentives were given for participation.
Study procedures and measurements
We conducted an internet based survey between September 2012 and April 2013. Our study
was advertised mainly in gay dating websites operating in Spain. Details about the study proce-
dures have been reported elsewhere [20]. Briefly, those who chose to access the survey website
were directed to an informative screen. Here, participants learned about the purpose of the
study and the estimated time to complete the questionnaire (15 min). They were also informed
about the fact that no Internet Protocols or cookies were collected and that data was collected
confidentially and anonymously. The questions were designed to elicit no identifying informa-
tion. Thus, participants were asked to report their age in years rather than their date of birth.
Likewise, we did not include questions on the city or town of residence; instead, we asked only
about the approximate number of inhabitants. Given the online nature of the study, written
consent was obtained by an “I agree to participate” button which was presented to participants
at the end of the informative screen. Once they clicked, they accessed the questionnaire. The
study and all its materials (including the questionnaire) were approved by the Carlos III health
institute ethical committee (CEI PI 70_2015). All procedures performed in studies involving
human participants were in accordance with ethical standards of the institutional research
committee and with the 1964 Helsinki declaration and its later amendments or comparable
ethical standards. Study did not include minors.
The questionnaire was designed in Spanish and collected data on socio-demography, life-
style, sexual behaviours, testing history and several aspects related to HIV self-testing. The
main outcome for this analysis was intention to use self-testing which was assessed with the
question “Would you have used a self-test for HIV, had it been available in pharmacies in
Spain?”. Replies initially were set as “yes”, “probably yes”, “not sure”, “probably no”, “no” and
were transformed into a binary variable for analysis: “yes/probably yes” and “I am not sure/
probably no/no”.
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To assess the barriers of access to HIV testing we used a question with eleven closed
response options and one open-ended. Participants were asked to choose their single most
important reason. For the analysis, they were recoded into a four-category variable, as follows:
A. Low perceived risk for HIV, which included the options: “I found myself very healthy”, “I
thought that with my behaviours I could not be infected”.
B. Fears of testing positive, which included: “Fear of the consequences for my health”, “Fear of
not being able to get / lose my job”, “Fear of not being able to get/lose a residence permit”,
“Fear of rejection or discrimination”.
C. Structural barriers, including the options: “I didn’t want to go to my GP/health center”,
“Concerns arising from the loss of anonymity while being tested”, “I knew I had to wait
several days to get the results”, “I wanted to do it in a private centre but had no money”,
“Feel discomfort answering intimate questions”
D. “Other reason”: To allow participants to express another reason not listed among the
aforementioned.
The questions of the survey used for this analysis can be found as supporting information
(S1 Appendix).
Statistical analysis
First, we performed a descriptive analysis of the main characteristics of never tested MSM.
Second, we calculated the proportion of participants that reported having intentions of
using a self-test if already available and cross-tabulated our data by relevant sociodemographic
and behavioral variables as well as by type of self-reported barrier for testing.
To address associations between intention to use self-testing and MSM characteristics, we
calculated crude and adjusted prevalence ratios (PRs) and their corresponding 95% confidence
intervals (CIs). We chose to use poisson regression with robust variance because it is a better
alternative than logistic regression in cross-sectional studies with frequent outcomes [21, 22].
All the statistically significant factors at p<0.2 in the single variable analysis were introduced a
multivariable regression model. We used the minimum Akaike information criteria (AIC) val-
ues to perform model comparisons and select the optimal model. Respondents with missing
data on> = 1 variables of the multivariable model, were not included in the regression model.
We performed the analysis using STATA 11 software (StataCorp, Texas, United States,
United States).
A third level of analysis, focused on those who reported intention to use a self-test. In this
group, we assessed the preference towards self-testing among all testing options, the type of
self-test preferred (blood/oral) and whether they would use it alone or accompanied by some-
one. We also assessed the number of times they would have used a self-test, in what way they
would incorporate it to their usual testing pattern, and what would be their preferred setting to
seek for a confirmation test if the self-test was reactive. This analysis has been stratified by the
type of barrier self-reported by participants and the relationship between the categorical vari-
ables was assessed using Pearson’s Chi-square test. Statistical significance was defined as a
two-tailed p value of less than 0.05.
Results
Some 91.8% of all participants were born in Spain, 44.8% were 30 years of age or older and
46.7% had finished a university degree. In the preceding 12 months, most had lived in Spain
(96.0%) in a city of more > = 100.000 inhabitants (58.1%). Additionally, 41.3% reported
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having had sex with men and women, 20.3% had kept their sex life with other men in total
secrecy and 60.2% were not related to the gay scene (Table 1).
More than half (56.0%) had had at least one unprotected anal intercourse (UAI) in the last
12 months, 7.2% had ever paid for sex, 4.1% had ever been paid for sex and 25.1% reported
having been diagnosed with a sexually transmitted infection (STI). Very few (1,1%) had ever
injected drugs (Table 1).
Regarding the reasons for never having been tested before, 48.2% of the participants
reported low perceived risk which included the following reasons “I thought that with my
behaviors I could not be infected “(37.3%) and “I found myself very healthy” (10.5%). Struc-
tural barriers were reported by 36.4% and included: “Concerns arising from the loss of ano-
nymity” (16.5%), “Feeling discomfort answering intimate questions” (8.3%), “I didn’t want to
go to my GP/health center” (7.7%), “I knew I had to wait several days to get the results” (1.9%),
“I wanted to do it in a private center but had no money” (1.5%). Fears derived from testing
positive were reported by 8.9% of the participants and included “Fear of the consequences for
my health” (6.1%),“Fear of rejection or discrimination” (2.1%), “Fear of not being able to get/
lose work” (0.5%) and “Fear of not being able to get/lose residence permit” (0.1%). The
remaining 6.4% of the participants reported “other reasons”.
The overall proportion of participants who reported intentions of using a self-test if already
available, was of 83.5% (95%CI: 82.0–84.9): 53.3% answered “yes” and 30.2% “probably yes”.
The results of the poisson regression analysis to assess the association of lifestyle and behav-
ioral characteristics with the intention to use self-testing are shown in Table 1. In the multivar-
iate model, variables that remained significantly associated with intention to use self-testing
were age of> = 30 years (PR, 95%CI: 1.05, 1.01–1.10), having had anal intercourse in the last
twelve months either protected or not (PR, 95%CI: 1.15, 1.02–1.30; PR, 95%CI: 1.21, 1.07–
1.37; respectively), reporting fears derived of testing positive (PR, 95%CI: 1.12, 1.05–1.20) and
structural barriers to get tested for HIV (PR, 95%CI: 1.23, 1.19–1.28 (Table 1). The proportion
of missing data of the independent variables are included as supplementary material (S1
Table)
The proportion of participants that identified self-testing as their preferred testing option
was of 78.3% and was higher among those who reported structural barriers (83.8%) than
among those who were never testers because of low risk perception (74.5%) or fear related rea-
sons (71.0%) (p<0.001). Almost half (45.9%) reported that they would be willing to use any of
the two self-testing options (blood or saliva) and 84.5% that they would prefer to use it alone
instead of with someone (Table 2).
Participants who reported fear and structural related barriers tended to think they would
have used it more times (p<0.001) than those who reported low risk perception or fear. If
approved, self-testing would always be used by 56.8% of the participants and those who
reported structural barriers chose this option more frequently (60.9%) than the other two
groups (p = 0.013) (Table 2).
In the case of receiving a positive result, the preferred confirmation sites would be primary
care (30.0%) and sexual health clinics (29.7%), although a substantial percentage of MSM with
fear related barriers (25.2%) reported not being sure of what would they do (p<0.001)
(Table 2).
Discussion
A large majority of the untested MSM we recruited online reported that they would have used
an HIV self-test if already available. Intention to use was especially high among older MSM
who reported anal intercourse in the las 12 months and among those who reported barriers to
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Table 1. Prevalence and factors associated with intention to use self-testing if already available among never tested MSM in Spain (N = 2,589a).
Total (N = 2589) Participants with
intentions to use self-
testing (N = 2161)
N % (col) n % (row) cPR 95% CIs P aPR 95% CIs
Age
<30 years old 1428 55.2 1160 81.2 1.00 1.00
�30 years old 1158 44.8 998 86.2 1.06 1.03–1.10 0.001 1.05 1.01–1.10
Education level
<University 1376 53.3 1159 84.2
�University 1206 46.7 997 82.7 0.98 0.95–1.02 0.288
Place of recidenceb
Latin-America 23 1.0 21 91.3 1.00 1.00
Other European country 64 2.7 50 78.1 0.86 0.71–1.03 0.091 0.86 0.70–1.05
Spain 2310 96.0 1938 83.9 0.92 0.81–1.04 0.193 0.93 0.79–1.08
Other Country 10 0.4 10 100.0 1.01 0.97–1.24 0.158 1.13 0.95–1.34
Settlement size (inhabitants)b
>100,000 1389 58.1 1156 83.2 1.00 1.00
<100,000 (within 30 km of a big city) 619 25.9 518 83.7 1.01 0.96–1.05 0.798 1.01 0.97–1.05
<100,000 (> = 30 km of a big city) 383 16.0 330 86.2 1.04 0.99–1.09 0.145 1.01 0.97–1.06
Cohabitationb
Lives alone 830 34.7 712 85.8 1.00 1.00
Lives with sexual partner 484 20.2 418 86.4 1.01 0.96–1.05 0.769 0.99 0.95–1.04
Lives with others (not a sexual partner) 1081 45.1 880 81.4 0.95 0.91–0.99 0.010 0.98 0.94–1.02
Sexual partners (lifetime)
Men & women 1070 41.3 898 83.9 1.00
Men only 1519 58.7 1263 83.1 0.99 0.96–1.03 0.598
Disclosure of sexual orientation
Has not disclosed his sexual orientation 492 20.3 403 81.9 1.00 1.00
Has disclosed his sexual orientation to someone 1937 79.7 1639 84.6 1.03 0.99–1.08 0.163 1.03 0.98–1.08
Relation with gay culture
Member of a gay CBOc 59 2.5 42 71.2 1.00 1.00
Not member of gay CBO but frequents the gay scene 875 37.3 755 86.3 1.21 1.03–1.43 0.022 1.08 0.93–1.27
Not related to gay scene 1410 60.2 1176 83.4 1.17 0.99–1.38 0.058 1.06 0.90–1.23
Anal intercourse & condom useb
No anal intercourse 129 5.3 86 66.7 1.00 1.00
Had, but all were protectedd 937 38.7 759 81.0 1.22 1.07–1.38 0.002 1.15 1.02–1.30
Had unprotected anal intercourse 1357 56.0 1190 87.7 1.32 1.16–1.49 0.001 1.21 1.07–1.37
Has been paid for sex
Yes 99 4.1 84 84.8 1.00
No 2340 95.9 1963 83.9 0.99 0.91–1.08 0.793
Has paid for sex
Yes 176 7.2 150 85.2 1.00
No 2266 92.8 1900 83.8 0.98 0.92–1.05 0.618
Injection drug use 2442
Never 2384 98.9 2002 84.0 1.00
Yes, > = 12 months ago 15 0.6 11 73.3 0.87 0.64–1.19 0.385
Yes, in the last 12 months 12 0.5 10 83.3 0.99 0.77–1.28 0.953
History of STIs
No 1798 74.9 1491 82.9 1.00 1.00
(Continued)
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Table 1. (Continued)
Total (N = 2589) Participants with
intentions to use self-
testing (N = 2161)
N % (col) n % (row) cPR 95% CIs P aPR 95% CIs
Lifetime diagnosis of STI 603 25.1 523 86.7 1.05 1.01–1.09 0.018 0.99 0.96–1.03
Main reason for not HIV testing
Low perceived risk for HIV 1236 48.2 936 75.7 1.00 1.00
Fear of testing positive 229 8.9 193 84.3 1.11 1.04–1.19 0.001 1.12 1.05–1.20
Structural barriers 931 36.3 884 94.9 1.25 1.21–1.30 0.000 1.23 1.19–1.28
Other 166 6.5 122 73.5 0.97 0.88–1.07 0.544 0.98 0.89–1.08
cPR: crude prevalence ratio; aPR: adjusted prevalence ratio; CI: confidence interval
a Due to missing data the numbers might not add up to totals
b In the last 12 months
c Community-Based Organization
d Protection referred to condom use only
https://doi.org/10.1371/journal.pone.0210637.t001
Table 2. Type of self-test preferred, aspects of the HIV self-testing process and potential use by type of barrier reported by those who expressed intention to use







N, % (row) 936 46.5 193 9.6 884 43.9 2013 100.0
Refers self-testing as the preferred testing option 697 74.5 137 71.0 741 83.8 1575 78.3 <0.001
Type of self-test preferred 0.60
Blood 128 13.9 30 15.9 129 14.8 287 14.5
Saliva 383 41.5 71 37.6 331 38.0 785 39.6
Either 412 44.6 88 46.6 411 47.2 911 45.9
How would you prefer to use a self-test kit? 0.64
Alone 785 84.7 157 82.2 742 84.9 1684 84.5
Acompanied by someone 142 15.3 34 17.8 132 15.1 308 15.5
Times a self-test would have been used if already available <0.001
Only once 482 51.8 56 29.0 317 36.2 855 42.8
Two to trhee times 357 38.3 100 51.8 403 46.0 860 43.0
Four or more times 92 9.9 37 19.2 156 17.8 285 14.2
Frequency of use if self-test kits were available 0.013
I would never/rarely use it, I rather get tested by a trained professional 129 14.3 30 16.1 93 10.9 252 13.0
It would be my usual testing method, although I would also seek testing by trained professionals 293 32.4 54 29.0 240 28.2 587 30.2
I would always use it 482 53.3 102 54.8 519 60.9 1103 56.8
Reaction following a positive self-test <0.001
Not sure what would I do 89 9.6 49 25.5 122 14.0 260 13.0
I would self-test again before taking a decision 132 14.2 27 14.1 146 16.7 305 15.3
I would seek for confirmation in a sexual health clinic 276 29.6 53 27.6 264 30.2 593 29.7
I would seek for confirmation in primary care 316 33.9 42 21.9 241 27.6 599 30.0
I would seek for confirmation in a private laboratory 62 6.7 10 5.2 54 6.2 126 6.3
I would seek for confirmation in a CBO/NGO 39 3.1 8 4.2 29 3.3 66 3.3
I would seek for confirmation in a family planning service, pharmacy or others 27 2.9 3 1.6 18 2.1 48 2.4
https://doi.org/10.1371/journal.pone.0210637.t002
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testing not related to risk perception. Among those who expressed willingness to self-test, a
large majority identified it as their preferred mode of testing and reported that, if available, they
would use this method exclusively. Most would attend primary care and sexual health clinics for
confirmatory purposes although a quarter of those expressing fear of the consequences of a pos-
itive result are not sure of what would they do if they obtained a positive result.
The percentage of untested MSM was slightly higher than that reported by a Spanish study
that also analyzed MSM recruited online (26%) [10]. We found three European studies that
assessed the willingness of MSM to use HIV self-testing kits [17–19] and proportions ranged
from 54.6% [19] to figures of nearly 90% and, therefore, very similar to our results [17, 18]. Of
these studies, only two assessed the association between testing history and willingness to use a
self-test kit [18, 19] and they present conflicting results. Whereas in the study by Greacen et al.
having never tested before was associated with interest in accessing an HIV test, in the study
by Rosales et al. it was the opposite and those with previous testing experience were the ones
that reported higher levels of interest in purchasing a self-test. Nevertheless, both of them
include testing history as an independent variable making it impossible to assess which partic-
ular sub-groups of never testers would benefit from its approval. As far as we know, the present
paper represents the first study at a European level that tries to distinguish which groups of
never-testers would use it if approved.
In this sense, the fact that older age is associated with willingness to use a self-test is an
important issue as they are more affected by late diagnosis in Spain [1] and elsewhere in
Europe [23]. It also means that it would benefit never tested MSM with longer periods at risk
of HIV acquisition and, hence, a subgroup with higher number of unknown infections as sug-
gested in several studies [24, 25]. The fact that participants involved in UAI in the last 12
months were the ones who reported higher willingness of using a self-test kit stresses the
potential of self-testing as a tool that could play an important role on promoting testing among
a hard to reach population who is not using pre-existing testing options in spite of being at
risk of acquiring HIV.
A key factor that has not been assessed until now is what type of barriers HIV self-testing
would help to remove. Populations with different barriers will be in the need of different test-
ing strategies. In this sense, according to our results, the group less benefited by the approval
of HIV self-testing kits would be those MSM that reported low risk perception. Low risk per-
ception affects the intention of actively seeking an HIV test and those reporting it could proba-
bly be better targeted by provider initiated strategies [26] and tailored interventions to increase
their risk perception.
Self-testing kits might be better fit for those who are not willing to access existing services
due to structural barriers or because of fears derived from a potential positive result. This is in
line with our results. Those facing structural barriers are a relevant group in size in our sample
and represent almost 4 in 10 of the untested MSM. In Spain, where testing services are pro-
vided in a large variety of contexts, structural barriers could have to do more with the accept-
ability rather than with the availability of services. In this sense, some characteristics of self-
testing such as complete anonymity, not having to deal with the anxiety of long periods of wait
for the test results, convenience, or not having to discuss one’s sex life with a health provider,
might be some of the reasons that make this testing option such a valued option for untested
MSM who reported structural barriers. Never tested participants affected by barriers related to
fears derived from a positive result are a much smaller group in size but would also benefit
greatly from the introduction of self-testing kits.
According to our results, self-testing could become a very popular option among untested
MSM. Most participants reported that it would become their favorite testing option and more
than half said that they would only use this option. This however represents a major challenge:
HIV self-testing in Spain
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providing HIV confirmation testing and linkage to care services for all those who obtain a pos-
itive self-test. In this sense, further studies should be carried out to monitor confirmation test-
ing and linkage to care among individuals receiving a positive self-test as data on the subject
are extremely scarce at the moment [27, 28]. Most of our participants reported that they would
seek for confirmation in the case of obtaining a positive self-test but, especially among those
who faced fear related barriers, there is a substantial group that reported not being sure of
what they would do in this scenario. It is important to ensure that in the case of obtaining a
positive result a confirmatory test is performed within a time period that allows fulfilling the
requirements of optimal linkage to care.
Several limitations need to be considered when interpreting these results. Although it is
true that online dating websites are an increasingly frequent way of socializing and meeting
new sex partners, the generalisation of these results to the overall untested MSM population
needs to be made with caution. The data analysed in this paper, was collected immediately
after the approval of self-testing in the US. Since then, self-testing has also been approved and
legalised in several other European countries. MSM could have become more knowledgeable
about it and some current opinions could be different to those from back in 2012–2013. Addi-
tionally, we do not know how answers based on the hypothetical situation of self-testing
already being marketed, can translate into actual use. Those who expressed intentions of using
it, could be reflecting a preference or sympathy towards this option. This however, does not
mean it would necessarily lead to the purchase and use of a self-test kit when made available.
The proportion of missing values among those who reported medium or low testing inten-
tions tended to be slightly higher than among those with high testing intentions (S1 Table).
This needs to be taken into account when interpreting the results as it could be leading to an
overestimation of those reporting high testing intentions. Nevertheless, its influence should be
minimal given that the proportion of missing data is always under the 10% mark (0.1%- 9.5%).
The difference of missing value rates should not change the interpretation of the results of our
main outcome variable which is very frequent (83.5%).
The high acceptability of this testing method underlines its capacity of being a potentially
relevant tool to promote testing among a severely undertested population. It would especially
benefit subpopulations of older age, that have been involved in unprotected anal sex and that
do not want to access already existing services due to structural barriers or because of fear
derived from a positive result. Its high potential impact also represents a major challenge to
ensure clear confirmation pathways to enable swift and effective linkage to care for those who
obtain a positive self-test result.
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References
1. Centro Nacional de Epidemiologı́a. Vigilancia Epidemiológica del VIH/SIDA en España. Sistema de
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